Fully booked: Senior Care: Technology, Investment Opportunities and Practices Go back »
-
Time2014-02-27 | 13:30 - 16:30
-
Venue:European Chamber Shanghai Office
-
Address:Unit 2204, Shui On Plaza 333 Huai Hai Zhong Road
-
Fee:Members: 300 |
Non Members: 500
We would love to hear your feedback, and it just takes a minute.
The European Chamber is pleased to invite you to a seminar on Senior Care: Technology, Investment Opportunities and Practices.
The demographic shift to an older society will have a profound impact on the Chinese economy and investment opportunities in China. Social Capital (Including Foreign Capital) Invested Medical Institution Market Access Issues is also one of the lobby issue in the healthcare sector. Many foreign elderly care technologies and services are aiming for the Chinese market. How is the current market access environment for foreign investment in the Senior Care practice? Is the playing field now level? What would be the market entry strategy? When to collaborate with (public & private) hospitals and elderly care real estate developers, or combine and sometimes draw a line?
This seminar will give you information on regulatory implications, and policy incentives and the feasibility to capture them. Our speakers will provide their insights and share their views.
Agenda
13.30-14.00 Registration
14.00-14.10 Welcome Remarks by Ms. Ying Rong Du, Vice-Chair of Pharma Working Group, European Chamber, Moderator
14.10-14.30 Presentation by Mr. ZHANG Naizi, Director of Shanghai No. 3 Elderly Home: Senior Care Policy and Practices inChina
14.30- 14:50 Presentation, by Ms. Katherine WANG, Ropes & Gray: Investment in China’s Elderly Healthcare Services: are policy hurdles out of the way?
14.50-15:10 Presentation by Mr. Chandlar WANG, KPMG: Analysis of Needs for Elderly Care and Service Design
15.10-15.30 Presentation by Ms. Jing FENG, NITA-Inbo: Smart Care Vision in China
15:30-16:30 Panel discussion and Q&A
Registration
Please register through this website (button above).
For any further enquiries, please contact Ms Eliza Zheng at ezheng@europeanchamber.com.cn or 63852023-117, stating your name and company, by Wednesday, 26 January 2014 COB.
Event Terms & Conditions
Please note that, though all are welcome to attend our events, we strongly recommend that you register online with us in advance so that we can keep you updated on any changes in the event schedule. From time to time, due to unforeseen circumstances we need to change the time or venue of an advertised event. So please do let us know by registering online if you plan to attend an event so that we can keep you informed.
Downloads
Speakers
Mr. Naizi Zhang
Mr. ZHANG Naizi has a medical degree from Nanjing South-East University and he had been studying in Japan during 1996 and 1998. After his overseas studies, Mr. ZHANG has been the Director of Shanghai No. 1 Elderly Home from 1998 to 2008 and from 2008 to date, he has been the Director of Shanghai No. 3 Elderly Home. Mr. ZHANG is very experienced in elderly care service, both theoretically and in practice. He and his No. 3 Elderly home are especially experienced and specialized in the care for elderly people with Alzheimer's.
Ms. Katherine Wang
Katherine Wang is the chief China life sciences advisor in Ropes & Gray LLP, Shanghai office. Katherine assists life science companies, healthcare service providers, and institutional investors in life science and healthcare sectors on a wide range of commercial and regulatory matters. Katherine represents companies in response to various requirements and inquiries from agencies including the National Health and Family Planning Commission (NHFPC), China Food and Drug Administration (CFDA) and the Administrations of Industry and Commerce (AICs), etc. She also assists institutional investors and corporate clients in structuring transactions and conducting regulatory due diligence on investment targets and prospective business partners in China. Before entering into private practice, Katherine served at McKinsey & Co., and subsequently as the head of AstraZeneca’s legal department in the Asia Pacific region. She is named the International Who’s Who of Life Sciences Lawyers (2013) and Chambers Asia’s Leading Lawyers in life sciences (2011 - 2013).
Mr. Chandlar Wang
Chandlar Wang has 10 years’ experience of healthcare consulting. He is a certified Lean & Six Sigma black belt and coach. His expertise is hospital strategy deployments, organization restructure, operations improvements, A&M, new hospital design, healthcare IT solutions, telehealth, eHealth. Before joining KPMG, Chandlar was a senior consultant at GE healthcare division. He was responsible for managing project teams in the design, development and delivery of client solutions. And leading teams to review and analyze client requirements or challenges and developing insightful proposals that ensure client satisfaction. Chandlar’s representative clients included BOH, NDRC, medical universities in China, level 3 & level 2 public hospitals in China, tier one hospitals in United States, and international pharmaceutical companies, such as Lily, GSK, Merck, Novo Nordisk, Novartis.
Ms. Jing Feng
Ms. Jing Feng is an Urban designer and Business Developer at Inbo, a large creative firm in the field of architecture, urban planning, consulting and engineering from the Netherlands. Jing Feng received her Master degree in Urbanism from Delft University of Technology in 2012. After graduation, she started working for Inbo in Rotterdam. Besides urban design projects, she did some research on Smart cities and Care projects in the Netherlands and China. Since Sep 2013, she was sent to work in Shanghai at NITA-Inbo.
Ms. Yingrong Du
Ms. Yingrong DU is the director of Abbott Global Government Affair China. She was appointed to this position in June 2011. Previously, she served in Chinese government for 27 years in the area of pharmaceutics. She was Deputy Director in department of drug safety & inspection of Beijing Drug Administration before joined Abbott. She had been Director in Department of Medicine and Medical Devices in Beijing Health Bureau for five years. She worked as Technical Officer in Medicine Cluster of WHO Headquarters, Genera, Switzerland for two years and Technical Inspector in Beijing Institute of Drug Control for three years. Yingrong joined Abbott in June 2011 and currently her priority includes: driver positions of industry associations (RDPAC and PhRMA) to engage Chinese government on policy shaping, includes pricing, tendering and EDL, etc.; develop communication channels with senior officer to delivery our key positions and messages; develop cooperation projects with third party to establish communication platform with hospital director and chief pharmacist; support to address market access issues by monitoring new policies and implementation. Yingrong earned her M.D. degree at Beijing University of Traditional Chinese Medicine, Faculty of Pharmacy, in China and MBA at University of Illinois, Champagne-Urbana, Illinois, in U.S.